While the drugs were developed to treat Type 2 diabetes, they have gained infamy for their dramatic weight loss effects (in the States, the FDA has approved them to help tackle obesity). A clinical ...

Biotech-stock investing has one tough test for success - and it's about to get easier ...

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...

RFK Jr could soon oversee Health in the US – here’s the areas he will have control over - Eric Garcia breaks down just how ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Should he make it through the nomination process, Kennedy plans to follow Trump’s mandate to remove “corruption” from HHS-led ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...

Here are 4 biotech stocks that could get a boost from a more open FDA regulatory climate The key to successful biotech investing is straightforward: Own stocks of companies that get drugs approved.

Citing the advent of other FDA-approved Dravet treatments, a company spokesperson noted that it had ... Eisai was originally ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

The Food and Drug Administration allows for licensed compounding pharmacies to make copies of certain drugs in short supply, and that has included semaglutide and tirzepatide, the main ingredients in ...